# Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma

> **NCT04611100** · NA · COMPLETED · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 70 (actual)

## Conditions studied

- Hilar Cholangiocarcinoma
- Biliary Obstruction

## Interventions

- **DEVICE:** ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea)

## Key facts

- **NCT ID:** NCT04611100
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04611100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04611100, "Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04611100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
